hims fda warning letter compounded semaglutide 2025 π¨ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these From Crackdown to Collaboration: FDA
Description
A recently published, randomized, placebo-controlled trial found a greater reduction in BMI z-score (0.22 SDs) in adolescents receiving liraglutide compared with placebo

Retatrutide hit 28.3% weight loss in the May 2026 trial
Looking for GLP-1 weight loss doctors in Rochester NY
95% confidence interval: 3.27, 19.20) was superior to that in overweight/obesity trials (2.23

Learn how it works, when it's available, and how to prepare.
See what MeAgain's free version includes and what premium adds.